Regional Hospital of Scranton Marks First In Cardiology In NEPA
Regional Hospital of Scranton's Dr. Raymond Resnick.
Regional Hospital of Scranton marked another first in cardiology in Northeastern Pennsylvania on February 29 when Raymond S. Resnick, MD, a cardiologist with Great Valley Cardiology Associates, inserted a newly-approved stent in a diabetic patient.
The Medtronic Resolute zotarolismus-eluting stent was approved last week by the United States Food and Drug Administration for use in patients with coronary artery disease (CAD). This is the first time the device was used in a cardiac catheterization in Northeast Pennsylvania.
A stent is a tube-like device introduced into an artery that has been blocked as a result of cardiovascular disease. Zotarolimus is a drug specifically developed to prevent re-blockage of arteries.
The patient, a 72-year-old diabetic with additional health issues, experienced a blockage in an artery in the front area of his heart. According to Dr. Resnick, the muscle supporting the blocked artery was healthy so he was able to poke through the blockage to insert the stent.
"The patient did wonderfully well and will probably go home tomorrow," Dr. Resnick says.
The Resolute zotarolismus-eluting stent is particularly useful in patients with diabetes who often experience more severe and recurring coronary blockages. "This system offers several benefits for all CAD patients, notably safety and the ease in which the stent is inserted," says Dr. Resnick. "The design of the stent system offers flexibility and range of motion which makes it easier for the interventional cardiologist to navigate the coronary arteries," he adds.
Dr. Resnick further explains that clinical trials of the Resolute zotarolismus-eluting stent show less chance of re-blockage.
"Here at Regional our goal is to ensure that physicians, patients and staff have the tools and support they need to achieve excellent outcomes for our patients," says Cindy Segar-Miller, chief operating officer, Regional Hospital of Scranton.
This stent system has been successfully used for years in Europe and Asia.